Skip to main content
. 2023;8(4):275–282.

Figure 1.

Figure 1

Kaplan Meier survival curves for: a) progression-free survival in all patients; b) overall survival in all patients; c) overall survival of patients with solitary versus other oligometastatic diseases (p=0.042); d) local control for patients with adrenal gland metastases treated with SBRT